人体类器官市场－全球产业规模、份额、趋势、机会及预测（依来源、器官类型、地区及竞争格局划分，2020-2030 年预测）

2024 年全球人类类器官市场价值为 5.1024 亿美元，预计到 2030 年将达到 6.4379 亿美元，预测期内复合年增长率为 4.15%。全球人类类器官市场正在经历显着增长，这得益于生物技术的进步、个人化医疗需求的不断增长以及专注于疾病建模和药物发现的研究活动的增加。类器官是由干细胞培育出的人体器官的三维微型版本，与传统方法相比，它为以更精确、更符合伦理道德的可持续方式研究人体生物学提供了一个创新平台。这个市场在製药、生物技术和学术领域越来越受到关注，为研究、药物测试和再生医学提供了一个有希望的途径。

关键市场驱动因素

医疗保健产业的成长

主要市场挑战

开发和研究成本高

主要市场趋势

药物研发与检验领域应用日益增多

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球人体类器官市场的影响

第五章：全球人类类器官市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依来源（成体干细胞、诱导性多能干细胞、胚胎干细胞、其他）
  • 依器官类型（胃模型、肠模型、肝臟模型、胰臟模型、肺部模型、脑部模型、肾臟模型、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美人体类器官市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲人体类器官市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区人类类器官市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲人体类器官市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲人类类器官市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：全球人类类器官市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• 美国典型培养物保藏中心（ATCC）
• 业务概览
• 公司概况
• 产品与服务
• 财务状况（据报告）
• 最新动态
• 主要人员详情
• SWOT分析
• 赛默飞世尔科技公司
• 加拿大干细胞技术公司
• 默克公司
• 康宁公司
• 生技公司
• ACROBIOSYSTEMS公司
• AMS生物技术（欧洲）有限公司
• Qkine有限公司
• PRIMACYT 细胞培养技术有限公司

第 16 章：策略建议

第17章调查会社について・免责事项

Global Human Organoids Market was valued at USD 510.24 Million in 2024 and is expected to reach USD 643.79 Million by 2030 with a CAGR of 4.15% during the forecast period. The global human organoids market is witnessing significant growth, driven by advancements in biotechnology, increasing demand for personalized medicine, and a rise in research activities focusing on disease modeling and drug discovery. Organoids, which are three-dimensional, miniature versions of human organs grown from stem cells, offer an innovative platform for studying human biology in a more precise and ethically sustainable way compared to traditional methods. This market is gaining traction across pharmaceutical, biotechnology, and academic sectors, offering promising avenues for research, drug testing, and regenerative medicine.

Key Market Drivers

Growth in Healthcare Industry

The growth of the global healthcare industry is a key driver of the human organoids market, propelling advancements in research, personalized medicine, and drug development. The healthcare industry ranks among the largest and most rapidly expanding sectors globally. In many developed countries, healthcare expenditures exceed 10 percent of the gross domestic product (GDP), representing a substantial portion of their economies. In the United States, healthcare spending increased by 2.7 percent in 2021, totaling USD 4.3 trillion, or USD 12,914 per capita. Healthcare spending also accounted for 18.3 percent of the nation's GDP. As healthcare systems worldwide continue to expand and evolve, there is a growing emphasis on innovative solutions to enhance the understanding of human biology, improve disease modeling, and accelerate the development of novel therapeutics. Human organoids-3D structures grown from stem cells that mimic the architecture and functionality of human organs-are becoming a critical tool in these advancements.

Key Market Challenges

High Costs of Development and Research

One of the key challenges facing the global human organoids market is the high costs associated with the development and research of these advanced biological models. The process of creating organoids, which involves cultivating stem cells to mimic the structure and function of human organs, requires cutting-edge technology, specialized expertise, and extensive laboratory resources. These factors contribute to significant upfront investment and ongoing operational expenses, which can hinder the widespread adoption and scalability of organoid technology.

The development of human organoids requires sophisticated equipment such as bioreactors, 3D cell culture systems, and precise imaging technologies, all of which are expensive to acquire and maintain. In addition, the cultivation of high-quality stem cells and the optimization of growth conditions to produce functional organoids are complex tasks that demand highly skilled personnel. Hiring and training researchers with the expertise to work with these intricate models further adds to the cost burden.

Key Market Trends

Rising Applications in Drug Discovery and Testing

The rising applications of human organoids in drug discovery and testing are emerging as a significant trend in the global human organoids market, transforming the way pharmaceutical research is conducted. Human organoids, which are lab-grown 3D structures that mimic the physiological and functional properties of human organs, offer a highly accurate platform for studying human diseases, testing new drugs, and predicting treatment outcomes. This innovative technology is gaining widespread adoption in the pharmaceutical industry, driven by the need for more efficient, cost-effective, and reliable drug development processes. In 2020, 53 new medicines were introduced, and over 9,000 compounds are currently in various stages of development worldwide. The research-driven biopharmaceutical sector is estimated to have invested USD 198 billion globally in R&D during that year.

Key Market Players

• American Type Culture Collection (ATCC)
• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Canada Inc.
• Merck KGaA
• Corning Incorporated
• Bio-Techne Corporation
• ACROBIOSYSTEMS INC.
• AMS Biotechnology (Europe) Ltd
• Qkine Ltd.
• PRIMACYT Cell Culture Technology GmbH

Report Scope

In this report, the Global Human Organoids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Organoids Market, By Source:

• Adult Stem Cells
• Induced Pluripotent Stem Cells
• Embryonic Stem Cells
• Others

Human Organoids Market, By Organ Type:

• Stomach Models
• Intestine Models
• Liver Models
• Pancreatic Models
• Lung Models
• Brain Models
• Kidney Models
• Others

Human Organoids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Organoids Market.

Available Customizations:

Global Human Organoids Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Human Organoids Market

5. Global Human Organoids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others)
  • 5.2.2. By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Human Organoids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By Organ Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Human Organoids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Source
      • 6.3.1.2.2. By Organ Type
  • 6.3.2. Mexico Human Organoids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Source
      • 6.3.2.2.2. By Organ Type
  • 6.3.3. Canada Human Organoids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Source
      • 6.3.3.2.2. By Organ Type

7. Europe Human Organoids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By Organ Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Human Organoids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Source
      • 7.3.1.2.2. By Organ Type
  • 7.3.2. Germany Human Organoids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Source
      • 7.3.2.2.2. By Organ Type
  • 7.3.3. United Kingdom Human Organoids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Source
      • 7.3.3.2.2. By Organ Type
  • 7.3.4. Italy Human Organoids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Source
      • 7.3.4.2.2. By Organ Type
  • 7.3.5. Spain Human Organoids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Source
      • 7.3.5.2.2. By Organ Type

8. Asia Pacific Human Organoids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By Organ Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Human Organoids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Source
      • 8.3.1.2.2. By Organ Type
  • 8.3.2. India Human Organoids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Source
      • 8.3.2.2.2. By Organ Type
  • 8.3.3. South Korea Human Organoids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Source
      • 8.3.3.2.2. By Organ Type
  • 8.3.4. Japan Human Organoids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Source
      • 8.3.4.2.2. By Organ Type
  • 8.3.5. Australia Human Organoids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Source
      • 8.3.5.2.2. By Organ Type

9. South America Human Organoids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By Organ Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Human Organoids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Source
      • 9.3.1.2.2. By Organ Type
  • 9.3.2. Argentina Human Organoids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Source
      • 9.3.2.2.2. By Organ Type
  • 9.3.3. Colombia Human Organoids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Source
      • 9.3.3.2.2. By Organ Type

10. Middle East and Africa Human Organoids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Source
  • 10.2.2. By Organ Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Human Organoids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Source
      • 10.3.1.2.2. By Organ Type
  • 10.3.2. Saudi Arabia Human Organoids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Source
      • 10.3.2.2.2. By Organ Type
  • 10.3.3. UAE Human Organoids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Source
      • 10.3.3.2.2. By Organ Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Human Organoids Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1.1. American Type Culture Collection (ATCC)
• 15.1.2. Business Overview
• 15.1.3. Company Snapshot
• 15.1.4. Products & Services
• 15.1.5. Financials (As Reported)
• 15.1.6. Recent Developments
• 15.1.7. Key Personnel Details
• 15.1.8. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. STEMCELL Technologies Canada Inc.
• 15.4. Merck KGaA
• 15.5. Corning Incorporated
• 15.6. Bio-Techne Corporation
• 15.7. ACROBIOSYSTEMS INC.
• 15.8. AMS Biotechnology (Europe) Ltd
• 15.9. Qkine Ltd.
• 15.10. PRIMACYT Cell Culture Technology GmbH

16. Strategic Recommendations

17. About Us & Disclaimer